Skip to main content
Top
Published in: International Urology and Nephrology 1/2007

01-03-2007 | Original Paper

Is there a relationship among age, international index of erectile function, international prostate symptom score, and aging males’ symptoms score?

Authors: Ali Atan, M. Murad Basar, Altug Tuncel, Cagatay Mert, Yilmaz Aslan

Published in: International Urology and Nephrology | Issue 1/2007

Login to get access

Abstract

Purpose

To investigate the relationship among the International Index of Erectile Function (IIEF), International Prostate Symptom Score (IPSS), and Aging Males’ Symptoms (AMS) scale scores in various age groups of males.

Patients and methods

A total of 307 male patients enrolled in the study. Mean age was 52.3 (range 21–77) years. Group 1 consisted of 51 (≤39 years), Group 2 consisted of 160 (40–59 years), and Group 3 consisted of 96 (≥60 years) patients. First five and 15th questions of the IIEF, IPSS, and AMS scale were replied by all the patients. The patients were assessed based on the IIEF for erectile dysfunction (ED), IPSS for lower urinary tract symptoms (LUTS), and AMS scale for Symptomatic Late-Onset Hypogonadism (SLOH).

Results

ED, LUTS, and SLOH symptoms were detected in 236 (76.8%), 162 (52.8%), and 184 (59.9%) patients. Except for total AMS scores, IIEF and IPSS scores were significantly different among the groups (p AMS = 0.320, p IIEF = 0.000, p IPSS = 0.000). In the comparisons of the IIEF scores between the each group, significant differences were observed (p Group1–Group2 = 0.000, p Group1–Group3 = 0.000, p Group2–Group3 = 0.000). Nevertheless, IPSS score was significantly lower in the patients with age ≤39 years than the other age groups (p = 0.000).

Conclusions

In the present study, ED ratio and LUTS severity significantly increased in older men. We did not find significant relationship between aging and SLOH symptoms. In the light of our results, LUTS seems to be an important risk factor on erectile function.
Literature
1.
go back to reference Diczfalusy E (1998) An aging humankind:is our future behind us? Aging Male 1:8–14 Diczfalusy E (1998) An aging humankind:is our future behind us? Aging Male 1:8–14
2.
go back to reference Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1557PubMed Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1557PubMed
3.
go back to reference Hafez B, Hafez ES (2004) Andropause:endocrinology, erectile dysfunction and prostate pathophysiology. Arch Androl 50:45–68PubMedCrossRef Hafez B, Hafez ES (2004) Andropause:endocrinology, erectile dysfunction and prostate pathophysiology. Arch Androl 50:45–68PubMedCrossRef
4.
go back to reference Morales A, Heaton JPI, Carson CC III (2000) Andropause:a misnomer for a true clinical entity. J Urol 163:705–712PubMedCrossRef Morales A, Heaton JPI, Carson CC III (2000) Andropause:a misnomer for a true clinical entity. J Urol 163:705–712PubMedCrossRef
5.
go back to reference Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5:74–86PubMed Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5:74–86PubMed
6.
go back to reference Heinemann LAJ, Zimmermann T, Vermuelen A, Thiel C (1999) A new aging males’ symptoms (AMS) rating scale. Aging Male 2:105–114CrossRef Heinemann LAJ, Zimmermann T, Vermuelen A, Thiel C (1999) A new aging males’ symptoms (AMS) rating scale. Aging Male 2:105–114CrossRef
7.
go back to reference Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF):a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830PubMedCrossRef Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF):a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830PubMedCrossRef
8.
go back to reference Moore C, Huebler D, Zimmermann T, Heinemann LAJ, Saad F, Thai DM (2004) The aging males’ symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46:80–87PubMedCrossRef Moore C, Huebler D, Zimmermann T, Heinemann LAJ, Saad F, Thai DM (2004) The aging males’ symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46:80–87PubMedCrossRef
9.
go back to reference Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates:results of the Massachusetts Male Aging Study. J Urol 151:54–61PubMed Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates:results of the Massachusetts Male Aging Study. J Urol 151:54–61PubMed
10.
go back to reference Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030CrossRef Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030CrossRef
11.
go back to reference Shabsigh R, Fishman IJ, Schum C, Dunn JK (1991) Cigarette smoking and other risk factors in vasculogenic impotence. Urology 38:227–231PubMedCrossRef Shabsigh R, Fishman IJ, Schum C, Dunn JK (1991) Cigarette smoking and other risk factors in vasculogenic impotence. Urology 38:227–231PubMedCrossRef
12.
go back to reference Kaufman JM, Vermeulen A (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11:289–309PubMedCrossRef Kaufman JM, Vermeulen A (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11:289–309PubMedCrossRef
13.
go back to reference Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total, free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86:724–731PubMedCrossRef Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total, free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86:724–731PubMedCrossRef
15.
go back to reference Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Pandian MR, Galmarini M, Bhasin S (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59:1118–1123PubMed Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Pandian MR, Galmarini M, Bhasin S (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59:1118–1123PubMed
16.
go back to reference Walsh PC (1992) Benign prostate hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s Urology, 6th edn. Saunders, Philadelphia WB,. pp 1007–1027 Walsh PC (1992) Benign prostate hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s Urology, 6th edn. Saunders, Philadelphia WB,. pp 1007–1027
17.
go back to reference Moncada I (2003) LUTS:a risk factor for sexual dysfunction in the BPH patient. Eur Urol suppl 2:3–8CrossRef Moncada I (2003) LUTS:a risk factor for sexual dysfunction in the BPH patient. Eur Urol suppl 2:3–8CrossRef
18.
go back to reference Rosen RC, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary M, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction:the Multi-National Survey of the Ageing Male (MSAM-7). Eur Urol 44:637–649PubMedCrossRef Rosen RC, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary M, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction:the Multi-National Survey of the Ageing Male (MSAM-7). Eur Urol 44:637–649PubMedCrossRef
19.
go back to reference Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH (2003) Lower urinary tract symptoms and erectile dysfunction:co-morbidity or typical “aging male” symptoms? results of the “Cologne Male Survey”. Eur Urol 44:588–594PubMedCrossRef Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH (2003) Lower urinary tract symptoms and erectile dysfunction:co-morbidity or typical “aging male” symptoms? results of the “Cologne Male Survey”. Eur Urol 44:588–594PubMedCrossRef
20.
go back to reference Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeu P, McCready D, Perry HM III (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239–1242PubMedCrossRef Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeu P, McCready D, Perry HM III (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239–1242PubMedCrossRef
21.
go back to reference T’Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM (2003) Self-referred patients in an aging male clinic:much more than androgen deficiency alone. Aging Male 6:157–165PubMed T’Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM (2003) Self-referred patients in an aging male clinic:much more than androgen deficiency alone. Aging Male 6:157–165PubMed
Metadata
Title
Is there a relationship among age, international index of erectile function, international prostate symptom score, and aging males’ symptoms score?
Authors
Ali Atan
M. Murad Basar
Altug Tuncel
Cagatay Mert
Yilmaz Aslan
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 1/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9153-y

Other articles of this Issue 1/2007

International Urology and Nephrology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine